Dirk O. Muegge
Wuerzburg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy.
Journal: Molecular imaging and biology
Published: August 16, 2018
Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy.
Journal: Molecular imaging and biology
Published: July 18, 2018
Aviscumine, a recombinant ribosomal inhibitor, increases the antitumor activity of natural killer cells.
Journal: Oncology letters
Published: October 18, 2016
Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.
Journal: Endocrine
Published: March 24, 2016
Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?
Journal: Nuclear medicine communications
Published: August 30, 2014
Video games do affect social outcomes: a meta-analytic review of the effects of violent and prosocial video game play.
Journal: Personality & social psychology bulletin
Published: January 25, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026